JW Pharmaceutical Corporation
KRX:001060.KS
23250 (KRW) • At close January 15, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) KRW.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities: | |||||||||||||||||
Net Income
| 35,096.028 | 29,852.56 | -1,441.453 | -15,275.471 | -25,275.016 | 8,056.889 | -742.474 | -10,933.544 | 1,961.427 | 1,446.877 | 2,274.88 | -20,393.601 | -9,803.596 | 5,600.272 | 10,918.718 | 6,433.178 | 8,761.048 |
Depreciation & Amortization
| 22,574.598 | 16,836.32 | 16,111.747 | 20,688.165 | 20,349.054 | 17,682.296 | 18,789.404 | 18,645.784 | 17,863.126 | 16,616.957 | 16,153.138 | 14,358.534 | 12,839.729 | 9,037.726 | 10,429.954 | 12,454.137 | 12,649.332 |
Deferred Income Tax
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Stock Based Compensation
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Change In Working Capital
| -20,262.513 | -6,169.67 | -46,055.78 | 35,217.301 | 62,912.458 | -393.621 | -15,515.89 | -14,565.929 | -37,919.731 | -19,853.949 | -5,773.79 | 53,254.314 | -31,111.635 | -44,929.689 | -53,964.118 | -41,256.118 | -29,804.607 |
Accounts Receivables
| -3,162.23 | -4,352.537 | -41,296.64 | 45,698.515 | 38,275.326 | 28,911.027 | -227.573 | -10,013.128 | -25,059.039 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventory
| 8,916.798 | -11,541.331 | -2,655.11 | -8,876.469 | 19,783.53 | -5,784.077 | -11,120.786 | -16,671.519 | -11,970.402 | 4,258.716 | -5,513.528 | 16,310.708 | 4,250.47 | 7,838.692 | -22,224.164 | -21,244.43 | -9,480.929 |
Accounts Payables
| -9,535.562 | 31,652.296 | 3,729.677 | 2,831.144 | -632.933 | -15,169.481 | 299.74 | 23,062.493 | 2,330.417 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Working Capital
| -16,481.519 | -21,928.098 | -5,833.707 | -4,435.889 | 5,486.535 | 5,390.456 | -4,395.104 | 2,105.59 | -25,949.329 | -24,112.665 | -260.262 | 36,943.606 | -35,362.105 | -52,768.381 | -31,739.954 | -20,011.688 | -20,323.678 |
Other Non Cash Items
| 49,749.123 | 16,245.228 | 49,509.469 | 22,424.371 | -2,455.411 | 26,764.369 | 30,919.132 | 13,592.325 | 13,920.248 | 9,069.213 | 6,070.276 | 16,995.535 | 9,891.764 | 18,612.525 | 21,496.688 | 21,020.806 | 23,212.876 |
Operating Cash Flow
| 87,157.236 | 56,764.439 | 18,123.982 | 63,054.367 | 55,531.085 | 52,109.933 | 33,450.172 | 6,738.636 | -4,174.93 | 7,279.098 | 18,724.504 | 64,214.782 | -18,183.738 | -11,679.166 | -11,118.758 | -1,347.997 | 14,818.649 |
Investing Activities: | |||||||||||||||||
Investments In Property Plant And Equipment
| -42,967.19 | -12,352.501 | -12,901.583 | -15,039.061 | -13,096.432 | -8,345.043 | -10,950.92 | -10,021.425 | -9,112.334 | -12,021.717 | -10,567.378 | -20,099.958 | -21,077.16 | -39,448.367 | -68,231.926 | -37,745.445 | -15,830.385 |
Acquisitions Net
| -12,004.964 | -40.884 | 384.964 | -5,625 | -5,349.145 | -5,178.86 | 31.389 | -1,616.121 | 3,555.891 | 18,243.203 | -6,249.532 | -1,966.968 | -9,916.854 | -9,009.253 | -2,003.551 | -3,064.511 | -1,000 |
Purchases Of Investments
| -61,344.003 | -73,817.4 | -140,023.467 | -56,346.636 | -15,470.959 | 644.401 | -214.488 | -58,045 | -660 | -2,510 | -30 | -162 | -226 | -22,651.048 | -600 | -2,336.573 | -93,521.546 |
Sales Maturities Of Investments
| 69,604.03 | 47,473.709 | 141,101.743 | 16.641 | 12,000 | 140 | 20 | 60,151.98 | 760.727 | 1,398.397 | 385.531 | 272.192 | 673.383 | 31,363.348 | 2,458.46 | 1,683.989 | 91,776.392 |
Other Investing Activites
| -17,122.143 | 19,817.917 | -11,430.809 | -2,433.237 | -67.196 | -1,178.865 | 1,040.005 | 760.695 | -1,890.926 | 5,712.766 | 6,284.895 | 2,140.653 | 11,338.947 | 9,816.49 | 5,051.602 | 4,223.964 | -597.257 |
Investing Cash Flow
| -63,834.27 | -18,919.16 | -22,869.152 | -79,427.292 | -21,983.732 | -13,918.367 | -9,890.915 | -8,769.871 | -7,346.642 | 10,822.648 | -10,176.483 | -19,816.082 | -19,207.685 | -29,928.83 | -63,325.415 | -37,238.576 | -19,172.796 |
Financing Activities: | |||||||||||||||||
Debt Repayment
| -28,189.796 | -36,523.302 | 36,960.383 | -4,625.036 | 9,700.728 | -15,307.394 | -22,138.983 | -74,468.945 | 9,798.107 | -37,483.548 | -28,468.297 | -53,407.04 | 31,775.147 | 41,797.938 | 74,470.667 | 40,504 | 8,299.737 |
Common Stock Issued
| 0 | 9,999.993 | 398.471 | 0 | 0 | 0 | 466.012 | 0 | 8,299.928 | 5,899.988 | 9,999.997 | 12,975.021 | 1,852.44 | 0 | 0 | 0 | 0 |
Common Stock Repurchased
| -260.875 | -281.6 | -412.292 | -224.245 | -258.458 | -9,370.637 | -317.286 | -218.636 | -37.655 | -42.755 | -40.107 | -44.282 | -46.267 | -60.2 | 0 | 0 | -2,102.936 |
Dividends Paid
| -8,813.671 | -7,351.968 | -7,149.5 | -6,953.837 | -6,815.539 | -5,820.291 | -5,884.381 | -2,711.662 | -2,694.37 | -1,752.506 | -1,449.578 | -2,043.504 | -2,940.681 | -2,856.067 | -2,767.247 | -2,686.742 | -2,974.423 |
Other Financing Activities
| -3,926.987 | -2,750.579 | -2,595.471 | -2,206.286 | -26,787.014 | -10,690.193 | -690 | 111,916.583 | -690 | 19,999.986 | 10,000 | -1,500 | 0 | 0.001 | 0 | 0 | -250.537 |
Financing Cash Flow
| -41,191.329 | -36,907.454 | 27,201.59 | -14,009.405 | -24,160.283 | -41,188.514 | -27,874.638 | 33,825.449 | 14,676.009 | -14,068.836 | -9,957.985 | -44,019.804 | 30,640.64 | 38,881.672 | 71,703.42 | 37,817.258 | 2,971.841 |
Other Information: | |||||||||||||||||
Effect Of Forex Changes On Cash
| -120.694 | -406.377 | 458.716 | -1,030.58 | 1,528.762 | 1,848.534 | -2,841.57 | -723.994 | 57.188 | -13.032 | -21.667 | -52.123 | -4.864 | 0 | 0 | 0 | -1,007.269 |
Net Change In Cash
| -17,989.057 | 531.448 | 22,915.136 | -31,412.91 | 10,915.831 | -1,148.415 | -7,156.951 | 31,070.219 | 3,211.625 | 4,019.877 | -1,431.631 | 326.773 | -6,755.647 | -2,726.324 | -2,740.753 | -769.315 | -2,389.575 |
Cash At End Of Period
| 15,908.868 | 33,897.925 | 33,366.477 | 10,451.341 | 41,864.252 | 30,948.42 | 32,096.835 | 39,253.786 | 8,183.567 | 4,971.941 | 952.064 | 2,383.694 | 2,056.922 | 8,636.027 | 11,362.351 | 14,103.104 | 14,872.419 |